Table 3.
Study | Year | No. patients | Agea (years) | Follow-up perioda (years) | Success rate (%) |
---|---|---|---|---|---|
Kumar et al. [14] | 2007 | 23 | N/A (<20) | Immediately post-op | 92 |
Pietila et al. [52] | 2001 | 74 | N/A (<17) | 0.8 (N/A) | 95 |
Parisini et al. [15] | 2001 | 129 | 16.2 (9–18) | Immediately post-op | 95 |
Papagelopoulos et al. [12] | 1998 | 72 | 16 (N/A) | N/A (<1.0) | 93 |
Luukkonen et al. [46] | 1997 | 12 | N/A (<15) | 0.5 (N/A) | 100 |
Shillito [11] | 1996 | 20 | N/A (10–15) | N/A (<3) | 100 |
Kurth et al. [32] | 1996 | 15 | N/A (<20) | Immediately post-op | 93 |
Silvers et al. [37] | 1994 | 15 | N/A (<21) | 0.3 (N/A) | 100 |
Ferrante et al. [53] | 1992 | 48 | 17.4 (13–20) | 0.3 (N/A) | 95.8 |
Ghabrial and Tarrant [54] | 1989 | 26 | N/A (13–18) | 1 (N/A) | 88 |
Plangger et al. [55] | 1989 | 11 | N/A (<19) | Immediately post-op | 100 |
Ebersold et al. [21] | 1987 | 60 | 15 (11–16) | 0.75 (N/A) | 95 |
Zucker et al. [1] | 1987 | 61 | N/A (10–18) | N/A (0.3–10) | 95 |
Epstein et al. [25] | 1984 | 25 | N/A (12–19) | N/A (2–4) | 96 |
DeOrio and Bianco [20] | 1982 | 50 | 15 (11–16) | Immediately post-op | 94 |
Garrido et al. [5] | 1978 | 30 | N/A (10–18) | N/A (0.5–5) | 93 |
Beks and ter Weeme [13] | 1975 | 43 | N/A (11–18) | 2 (N/A) | 100 |
Borgesen and Vang [56] | 1974 | 24 | N/A (11–19) | 4.2 (N/A) | 79 |
Bulos [33] | 1973 | 5 | N/A (14–19) | N/A (1–3.5) | 100 |
Rugtveit [57] | 1966 | 7 | N/A (11–17) | 4.9 (N/A) | 100 |
Epstein et al. [3] | 1964 | 10 | N/A (15–19) | N/A (<4) | 100 |
O’Connell [58] | 1960 | 38 | N/A (15–20) | Immediately post-op | 100 |
N/A Not available
aThe values are given as the means, with the ranges in the parenthesis